AMZN
Amazon.com, Inc.
AMZN has the edge over CBRL overall, supported by stronger valuation and stronger modeled upside.
CBRL
Cracker Barrel Old Country Store, Inc.
CBRL's outlook is improving despite an expensive valuation.
AMZN Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| Weak | |
| Healthy |
AMZN's revenue, profitability and balance sheet are currently healthy, but its cash flow is weak.
CBRL Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Stable | |
| Healthy | |
| Stable |
CBRL's cash flow is currently healthy, and its revenue, profitability and balance sheet are stable.
AMZN PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 22x | $267 | — |
| Forward | 27x | $267 | — |
| Cheap | 34x | $415 | +55% |
| Fair | 60x | $745 | +179% |
| Expensive | 102x | $1,262 | +372% |
Historical ranges are pointers, not guarantees.
AMZN has the edge over CBRL in the historical PE scenario, which offers more potential upside but is not a forecast.
CBRL PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 15x | $21.10 | -67% |
| Fair | 21x | $29.24 | -55% |
| Forward | 31x | $64.86 | — |
| Expensive | 39x | $54.48 | -16% |
| Current | 46x | $64.86 | — |
Historical ranges are pointers, not guarantees.
CBRL's PE is in its expensive range at 46x. If earnings grow as analysts expect, today's price would be 31x next year's earnings.
AMZN Forward outlook
| Metric | Outlook |
|---|---|
| Strongly deteriorating | |
| Strong growth | |
| Growth | |
| Improving | |
| Moderate | |
| Moderate |
Analysts expect earnings and revenue growth for AMZN, with profitability improving.
CBRL Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Returning to profit | |
| Stable | |
| Strongly improving | |
| Limited | |
| Moderate |
Analysts expect CBRL to return to profit, with revenue holding steady.
AMZN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $9.87 | -20% |
| Q3 2026 | $12.37 | +75% |
| Q2 2026 | $12.43 | +89% |
| Q1 2026 | $8.36 | +36% |
| Q4 2025 | $7.17 | +30% |
| Q3 2025 | $7.08 | +52% |
| Q2 2025 | $6.56 | +57% |
| Q1 2025 | $6.14 | +72% |
| Q4 2024 | $5.53 | +91% |
AMZN has the edge over CBRL on earnings, with more consistent year-over-year improvement.
CBRL Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $2.10 | +50% |
| Q3 2026 | $1.40 | -32% |
| Q2 2026 | $1.15 | -55% |
| Q1 2026 | -$0.19 | -112% |
| Q4 2025 | $0.74 | -59% |
| Q3 2025 | $2.06 | +13% |
| Q2 2025 | $2.57 | -5.2% |
| Q1 2025 | $1.60 | -57% |
| Q4 2024 | $1.80 | -54% |
CBRL's earnings per share have fallen from their peak: $1.40 over the past year, against $10.71 in mid-2021.
AMZN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $201.9B | +12% |
| Q2 2026 | $200.6B | +20% |
| Q1 2026 | $181.5B | +17% |
| Q4 2025 | $213.4B | +14% |
| Q3 2025 | $180.2B | +13% |
| Q2 2025 | $167.7B | +13% |
| Q1 2025 | $155.7B | +8.6% |
| Q4 2024 | $187.8B | +10% |
AMZN has the edge over CBRL on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 14% | +4.2 points |
| Q2 2026 | 14% | +2.3 points |
| Q1 2026 | 13% | +1.3 points |
| Q4 2025 | 12% | +0.4 points |
| Q3 2025 | 9.7% | -1.3 points |
| Q2 2025 | 11% | +1.5 points |
| Q1 2025 | 12% | +1.1 points |
| Q4 2024 | 11% | +3.5 points |
AMZN has the edge over CBRL on profitability, with a higher operating margin.
CBRL Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $849.3M | -2.2% |
| Q2 2026 | $797.4M | -2.9% |
| Q1 2026 | $874.8M | -7.9% |
| Q4 2025 | $797.2M | -5.7% |
| Q3 2025 | $868M | -2.9% |
| Q2 2025 | $821.1M | +0.5% |
| Q1 2025 | $949.4M | +1.5% |
| Q4 2024 | $845.1M | +2.6% |
CBRL's revenue is shrinking: $849M last quarter, down 2.2% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 1.6% | +1.1 points |
| Q2 2026 | 0.8% | -1 points |
| Q1 2026 | 0.1% | -3 points |
| Q4 2025 | -4.1% | -5 points |
| Q3 2025 | 0.5% | -2 points |
| Q2 2025 | 1.8% | +4.2 points |
| Q1 2025 | 3.1% | -0.2 points |
| Q4 2024 | 0.8% | -0.5 points |
CBRL's operating margin was 1.6% last quarter, up 1.1 points from the same quarter a year ago.
AMZN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$34.8B | -8202% |
| Q2 2026 | -$8.8B | -2757% |
| Q1 2026 | -$18.2B | -$10.2B |
| Q4 2025 | $14.9B | -16% |
| Q3 2025 | $430M | -87% |
| Q2 2025 | $332M | -96% |
| Q1 2025 | -$8B | -297% |
| Q4 2024 | $17.8B | -36% |
AMZN's free cash flow was −$46.9B over the past year, against $10.6B the year before.
CBRL Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $86M | +52% |
| Q2 2026 | $66.9M | +$80.5M |
| Q1 2026 | $24.5M | -59% |
| Q4 2025 | -$88.9M | -$45.6M |
| Q3 2025 | $56.8M | +157% |
| Q2 2025 | -$13.6M | -266% |
| Q1 2025 | $60M | +18% |
| Q4 2024 | -$43.3M | -$2.8M |
CBRL has the edge over AMZN on cash generation, producing positive trailing cash flow while its opponent burns cash.
AMZN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.2% | +26M shares |
| 1 year | +0.8% | +84M shares |
| 3 years | +3.5% | +371M shares |
| 5 years | +6.1% | +629M shares |
| Available history | +8.2% | +829M shares |
AMZN has 10.9B diluted shares, up 0.8% from a year ago.
| Quarter | Spent |
|---|---|
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
| Q2 2023 | — |
| Q1 2023 | — |
| Q4 2022 | — |
| Q3 2022 | — |
| Q2 2022 | $3.3B |
CBRL Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.2% | +45K shares |
| 1 year | +0.4% | +81.2K shares |
| 3 years | +1.3% | +280K shares |
| 5 years | -5.1% | -1.2M shares |
| Available history | -6.5% | -1.6M shares |
CBRL has the edge over AMZN on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q2 2024 | — |
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
| Q2 2023 | — |
| Q1 2023 | $5M |
| Q4 2022 | $12.4M |
| Q3 2022 | $58.1M |
AMZN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.7x | Very low |
| Q2 2026 | 0.3x | Very low |
| Q1 2026 | 0.1x | Very low |
| Q4 2025 | -0.1x | Net Cash |
| Q3 2025 | -0.1x | Net Cash |
| Q2 2025 | -0.0x | Net Cash |
| Q1 2025 | -0.1x | Net Cash |
| Q4 2024 | -0.2x | Net Cash |
AMZN has the edge over CBRL on leverage, with a lower net debt burden relative to earnings.
CBRL Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 2.7x | Moderate |
| Q2 2026 | 4.5x | High |
| Q1 2026 | 4.8x | High |
| Q4 2025 | 3.9x | Elevated |
| Q3 2025 | 2.5x | Moderate |
| Q2 2025 | 2.5x | Moderate |
| Q1 2025 | 3.0x | Moderate |
| Q4 2024 | 3.3x | Elevated |
CBRL's net debt is about 2.7 years of its operating earnings (EBITDA), up from 2.5 years a year ago.
AMZN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 57.1 | Neutral |
| Stochastic | 50.0 | Neutral |
AMZN's weekly RSI is 57 (neutral) and its Stochastic is 50 (neutral).
CBRL Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 63.9 | Neutral |
| Stochastic | 77.0 | Neutral |
CBRL's weekly RSI is 64 (neutral) and its Stochastic is 77 (neutral).
AMZN PE vs Consumer Cyclical Sector
| Metric | AMZN | Sector median | Relative |
|---|---|---|---|
| PE | 22x | 18x | 20% above |
| PE % | 4 | 47 | 43 pts below |
AMZN has the edge over CBRL on valuation relative to its sector.
CBRL PE vs Consumer Cyclical Sector
| Metric | CBRL | Sector median | Relative |
|---|---|---|---|
| PE | 46x | 18x | 157% above |
| PE % | 88 | 47 | 41 pts above |
CBRL is trading at 46x earnings, a 157% premium to the Consumer Cyclical sector's median of 18x.
AMZN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $253.6 | 5.5% above |
| 20 week MA | $254.9 | 4.9% above |
| 50 week MA | $242.5 | 10% above |
| 100 week MA | $229.6 | 17% above |
| 200 week MA | $191.4 | 40% above |
AMZN is in an uptrend: it's above all five of its weekly moving averages, and 40% above its 200-week average.
CBRL Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $62.7 | 3.5% above |
| 20 week MA | $57.4 | 13% above |
| 50 week MA | $42.1 | 54% above |
| 100 week MA | $45.8 | 41% above |
| 200 week MA | $59.2 | 9.5% above |
CBRL has climbed back above all five of its weekly moving averages, and it's now 9.5% above its 200-week average.
AMZN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $93.5 | $158.6 | +70% |
| 2021 | $158.6 | $171.1 | +7.8% |
| 2022 | $171.1 | $85.3 | -50% |
| 2023 | $85.3 | $151.9 | +78% |
| 2024 | $151.9 | $223.8 | +47% |
| 2025 | $223.8 | $232.5 | +3.9% |
| 2026 YTD | $232.5 | $267.4 | +15% |
AMZN has finished higher in five of the last six years, two of them by more than 50%. It's up 15% so far in 2026.
CBRL Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $154.8 | $135.1 | -13% |
| 2021 | $135.1 | $128.1 | -5.2% |
| 2022 | $128.1 | $97.1 | -24% |
| 2023 | $97.1 | $77.1 | -21% |
| 2024 | $77.1 | $56.4 | -27% |
| 2025 | $56.4 | $26.0 | -54% |
| 2026 YTD | $26.0 | $64.9 | +150% |
CBRL has the edge over AMZN on returns for 2026, with the stronger performance.